Do adjuvant aromatase inhibitors increas
β
Federica Cuppone; Emilio Bria; Sunil Verma; Kathleen I. Pritchard; Sonal Gandhi;
π
Article
π
2008
π
John Wiley and Sons
π
English
β 203 KB
π 1 views
## Abstract ## BACKGROUND. Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of CanadaβCommon Toxicity Criteria [version